United States securities and exchange commission logo September 23, 2022 Vlad Coric, M.D. Chief Executive Officer Biohaven Pharmaceutical Holding Co Ltd. 215 Church Street New Haven, CT 06510 Re: Biohaven Pharmaceutical Holding Co Ltd. Preliminary Proxy Statement on Schedule 14A Filed July 1, 2022 File No. 001-38080 Dear Dr. Coric: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert Downes, Esq.